Question

I am a breastfeeding mother and i want to know if it is safe to use MK 4827 (Base)? Is MK 4827 (Base) safe for nursing mother and child? Does MK 4827 (Base) extracts into breast milk? Does MK 4827 (Base) has any long term or short term side effects on infants? Can MK 4827 (Base) influence milk supply or can MK 4827 (Base) decrease milk supply in lactating mothers?

Answer by DrLact: About MK 4827 (Base) usage in lactation

No information is available on the clinical use of MK 4827 (Base) during breastfeeding. Because MK 4827 (Base) is 83% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during MK 4827 (Base) therapy and for 1 month following therapy.

Alternate Drugs

Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Cladribine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Docetaxel(Dangerous)
Pazopanib(Unsafe)
Bevacizumab(Low Risk)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Nilotinib(Unsafe)
Hydroxyurea(Low Risk)
Trastuzumab(Unsafe)
Etoposide(Dangerous)
Doxorubicin(Dangerous)
Gemcitabine(Dangerous)
Dactinomycin(Dangerous)
Ipilimumab(Unsafe)
Letrozole(Dangerous)
Cyclophosphamide(Dangerous)
Cetuximab(Unsafe)
Exemestane(Dangerous)
Cisplatin(Unsafe)
Nivolumab(Unsafe)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Busulfan(Dangerous)
Vinblastine(Dangerous)
Paclitaxel(Dangerous)
Erlotinib(Unsafe)
Bleomycin(Dangerous)
Pazopanib(Unsafe)
Orlistat(Low Risk)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Imatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Erlotinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.